Yes-associated protein isoform 1 (Yap1) promotes cardiomyocyte survival and growth to protect against myocardial ischemic injury - Wikidata - awgldk - TriplyDB

Yes-associated protein isoform 1 (Yap1) promotes cardiomyocyte survival and growth to protect against myocardial ischemic injury

Yes-associated protein isoform 1 (Yap1) promotes cardiomyocyte survival and growth to protect against myocardial ischemic injury

http://www.wikidata.org/entity/Q36596197

about

Harnessing Hippo in the heart: Hippo/Yap signaling and applications to heart regeneration and rejuvenation Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer miR-206 Mediates YAP-Induced Cardiac Hypertrophy and Survival The Hippo pathway in tissue homeostasis and regeneration.Deletion of yes-associated protein (YAP) specifically in cardiac and vascular smooth muscle cells reveals a crucial role for YAP in mouse cardiovascular development.The Hippo pathway in disease and therapy: cancer and beyond The hippo pathway in heart development, regeneration, and diseases Alpha-catenins control cardiomyocyte proliferation by regulating Yap activity.G Protein-Coupled Receptor and RhoA-Stimulated Transcriptional Responses: Links to Inflammation, Differentiation, and Cell Proliferation.YAP1 Exerts Its Transcriptional Control via TEAD-Mediated Activation of Enhancers Cardiomyocyte-specific overexpression of the ubiquitin ligase Wwp1 contributes to reduction in Connexin 43 and arrhythmogenesis.Involvement of the Hippo pathway in regeneration and fibrogenesis after ischaemic acute kidney injury: YAP is the key effector MicroRNA-34a Plays a Key Role in Cardiac Repair and Regeneration Following Myocardial Infarction.The Hippo signal transduction network for exercise physiologists Hippo signaling impedes adult heart regeneration.A functional interaction between Hippo-YAP signalling and FoxO1 mediates the oxidative stress response.Amotl1 mediates sequestration of the Hippo effector Yap1 downstream of Fat4 to restrict heart growth.Extra- and intracellular factors regulating cardiomyocyte proliferation in postnatal life.An emerging role for Hippo-YAP signaling in cardiovascular development.Targeting pleiotropic signaling pathways to control adult cardiac stem cell fate and function.The Hippo signal transduction network in skeletal and cardiac muscle.Hippo signaling in stress response and homeostasis maintenance.The regulation and function of YAP transcription co-activator.Cardiac Regeneration: Lessons From Development.The hippo signaling pathway: implications for heart regeneration and disease.Signaling Pathways in Cardiac Myocyte Apoptosis.Hippo/Yap Signaling in Cardiac Development and Regeneration.Retinal Degeneration Triggers the Activation of YAP/TEAD in Reactive Müller Cells.Redirecting cardiac growth mechanisms for therapeutic regeneration.Hippo vs. Crab: tissue-specific functions of the mammalian Hippo pathway.A growing role for the Hippo signaling pathway in the heart.Hippo Pathway: An Emerging Regulator of Craniofacial and Dental Development.The eIF2α serine 51 phosphorylation-ATF4 arm promotes HIPPO signaling and cell death under oxidative stress.mTORC2 regulates cardiac response to stress by inhibiting MST1.Gene transfer to promote cardiac regeneration.A microRNA-Hippo pathway that promotes cardiomyocyte proliferation and cardiac regeneration in mice.NF2 Activates Hippo Signaling and Promotes Ischemia/Reperfusion Injury in the Heart.Cardiac regeneration in model organisms.Pi3kcb links Hippo-YAP and PI3K-AKT signaling pathways to promote cardiomyocyte proliferation and survival.The Hippo pathway effector YAP is a critical regulator of skeletal muscle fibre size.

P2860

Q26995264-DC6AF690-A504-446C-A5D8-E252EDA2891B Q28269498-7B851379-7FC2-4BB8-833F-5C7CAFFE4B3E Q28579456-C9A138A0-918D-4050-9C57-A6AC702758DE Q33628097-E5D124EE-B4AD-4CD1-AB63-391C79666862 Q33725751-C6D1B6DA-4ED3-49A5-84A6-DACFFBE57045 Q33937666-4BA45EA6-822A-4A87-A05D-1274D172ECF3 Q34470968-3468783D-6E65-49CA-AD26-A78F9AD38EFD Q34807247-C044C0E8-BA7E-416D-A7D1-AA34CCDA1942 Q35745964-80A721AE-808B-4781-BFCE-5319EB5560E2 Q35752339-6E1E0D54-AD39-4B98-9303-7FEE187818D3 Q36269300-8D985FD4-C633-4C31-A244-9F352D74C21C Q36504430-43EF5F5F-18F8-443E-8F8C-4E40ED190885 Q36626642-CDF2A162-E92B-4677-BE4F-E1B261BEE371 Q36902243-1E98948A-E558-4462-8998-CD206C5766E2 Q37323625-63697E38-2EBF-4581-976C-7E305B0E1059 Q37656609-D574604B-2303-4A94-AE83-339E887F1123 Q37676704-07EF8623-F690-4D40-B456-1B57B03B2DE9 Q38195538-CCC64315-EF76-4698-A6D4-45DCAFAE6EC2 Q38232581-2AAB2832-15FD-4C12-BD19-2E980E6F81FC Q38234910-4BB9E583-CE44-4E16-9644-E06A73521EE5 Q38237345-D0D23FD7-20D0-473E-979F-08D3135ACBBC Q38283345-F51ACCFF-1BCD-4A34-9361-781E0A57AA15 Q38285451-0171F491-DA7F-4393-B02F-CA494CF1D255 Q38743894-7D77B105-01DD-4DE1-B69D-7B2B98BB84EE Q38757064-0072E53A-5680-4503-8D7E-296A0762E3B6 Q38768739-5785C0E8-DE2A-4CA7-B6FE-1EE60B560315 Q38796986-C6109DEE-B150-479C-8892-5539542D56F5 Q38849795-BE1CCD63-FB64-45D2-87CE-6118DCE0A8FA Q38987181-B46A3D04-D365-4AB0-9379-C0BEF6926D7C Q39081825-56332C6C-5D2D-43FA-9E99-CDBD6EE6FDBF Q39172264-182A3051-89E7-44C8-8664-62E621297856 Q39430587-DC5F4BDD-1EDB-4CE3-ABA5-455E33418F74 Q39606799-C29842A1-F510-4EEC-9A60-79DCEF384A34 Q40182849-60D0AEBC-AAE9-421B-BB6B-3C17B6DC5D2B Q40802294-0AB23159-AA59-4943-8993-9649D460B42D Q41196397-F44D7DC7-B8F1-4F9B-B4E0-0C83600653F4 Q41492288-C925D84E-392C-40AE-A30C-C907DCACFEDB Q41783661-247AD0C4-5999-46ED-9183-FD161E334AE0 Q42159137-0A741D5F-184C-41D0-A925-7EC30273087F Q42471372-EA95063E-EBD2-42BA-AAF2-52A58B38598E

P2860

Yes-associated protein isoform 1 (Yap1) promotes cardiomyocyte survival and growth to protect against myocardial ischemic injury

http://www.wikidata.org/entity/Q36596197

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Yes-associated protein isoform ...... nst myocardial ischemic injury

@ast

Yes-associated protein isoform ...... nst myocardial ischemic injury

@en

type

label

Yes-associated protein isoform ...... nst myocardial ischemic injury

@ast

Yes-associated protein isoform ...... nst myocardial ischemic injury

@en

prefLabel

Yes-associated protein isoform ...... nst myocardial ischemic injury

@ast

Yes-associated protein isoform ...... nst myocardial ischemic injury

@en

P1433

Q36596197-533034A4-C5A7-49A7-92E4-A0138E2D7AA8

P1476

Q36596197-09738081-E37C-4E62-AA99-54F015B4669A

P2093

Q36596197-006798B5-5FB9-4FDC-936D-6C1B9E94FCA9

Q36596197-1D2F221C-08A2-493E-A7D9-7ECC6A3EE881

Q36596197-216724CA-B12C-460C-92BD-37E62EA5A5C3

Q36596197-4C67E688-A5EB-4299-BC32-34B1EC2BAF92

Q36596197-7C1DC11E-DBDA-4F09-AA94-74D72E4DA277

Q36596197-89BE4065-8734-4A7C-9E5F-9F5565B58F8C

Q36596197-8A572591-16B3-46E4-A8BB-C3C7AD781750

Q36596197-8E2242D1-55F1-4149-9E6B-8CCC59A77B87

Q36596197-AFE16F36-9B17-414B-A3A4-99A2539C0BFC

Q36596197-FC339225-D114-4C31-9AEC-88C877D0CD5E

P2860

Q36596197-05C646EF-B8FC-4997-9AFD-AF518C875EC9

Q36596197-0A764936-A11D-4AB6-932F-A95F217F3D70

Q36596197-0C941519-3B16-4600-9918-2D8C4312A8E5

Q36596197-160F9366-45CA-463C-BFA2-66DBBAB8355E

Q36596197-1970D7B9-05EB-4DC7-B587-6307507F5313

Q36596197-19B409AE-6687-4F09-97A1-9399424E9498

Q36596197-2E6E8914-0D6A-49F3-A64D-3823782EAB1D

Q36596197-38193530-B9BB-4D44-81FF-6EDD0501ECE4

Q36596197-3A5201C0-1534-4CC8-9290-F52ABF71F6F8

Q36596197-47B51F32-8D3E-4E53-8045-7518EDD48F70

P304

Q36596197-AE42BB27-DC17-41FD-AA35-615F55E76529

P31

Q36596197-46559C11-8C28-4648-8E79-4A8CC1755794

P356

Q36596197-CDC237D7-3B3A-40CF-83C1-67858E49BB27

P407

Q36596197-381AC69C-E434-4892-879A-BF63731DE3AC

P433

Q36596197-500AEFC3-E448-4F83-9FA4-D6C76E50161B

P478

Q36596197-93CBF28F-2B0F-42B1-881A-FC159B328912

P50

Q36596197-BDBA9AD9-912E-4F12-8971-4825A81B4428

P577

Q36596197-F89807DB-C3D5-4C86-BBBE-604402820064

P5875

Q36596197-6318FEB0-DC45-4FA9-AE46-49EEFDA8FC99

P698

Q36596197-6C93E78B-CC97-4809-8174-B05855A5104F

P932

Q36596197-C0EC875D-E287-412D-AC1B-2EBB83909447

P356

JBC.M112.436311

P1433

Journal of Biological Chemistry

P1476

Yes-associated protein isoform ...... nst myocardial ischemic injury

@en

P2093

Dominic P Del Re

http://www.w3.org/2001/XMLSchema#string

Duojia Pan

http://www.w3.org/2001/XMLSchema#string

Hiroshi Nojima

http://www.w3.org/2001/XMLSchema#string

Jaeyeaon Cho

http://www.w3.org/2001/XMLSchema#string

Nailing Zhang

http://www.w3.org/2001/XMLSchema#string

Norikazu Yabuta

http://www.w3.org/2001/XMLSchema#string

Noritsugu Nakano

http://www.w3.org/2001/XMLSchema#string

Peiyong Zhai

http://www.w3.org/2001/XMLSchema#string

Takanobu Yamamoto

http://www.w3.org/2001/XMLSchema#string

Yanfei Yang

http://www.w3.org/2001/XMLSchema#string

P2860

The hippo signaling pathway in development and cancer

The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version

Myocardial fibrosis and stiffness with hypertrophy and heart failure in the spontaneously hypertensive rat

Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size

Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver

Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression

YAP1 increases organ size and expands undifferentiated progenitor cells

Elucidation of a universal size-control mechanism in Drosophila and mammals

Evidence that human cardiac myocytes divide after myocardial infarction.

The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals.

P304

3977-3988

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M112.436311

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

288

http://www.w3.org/2001/XMLSchema#string

P50

Junichi Sadoshima

P577

2012-12-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

234012021

http://www.w3.org/2001/XMLSchema#string

P698

23275380

http://www.w3.org/2001/XMLSchema#string

P932

3567650

http://www.w3.org/2001/XMLSchema#string